Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon γ): Inhibition by immunoglobulin A complexes

Journal of Experimental Medicine

Volumn 190, Issue 4, 1999, Pages 487-495

  Woerly, Gaëtane ^a   Roger, Nadine ^a   Loiseau, Sylvie ^a   Dombrowicz, David ^a   Capron, André ^a   Capron, Monique ^a,b  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

CD28; CD86; Eosinophils; Secretory IgA; Type 1 cytokines

Indexed keywords

CD28 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 2;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHIL; HUMAN; HUMAN CELL; HYPEREOSINOPHILIA; IMMUNOREGULATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD86; COLONIC NEOPLASMS; EOSINOPHILIA; EOSINOPHILS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033575793     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.4.487     Document Type: Article

References (32)

1. Weller, P.F. 1997. Updates on cells and cytokines: human eosinophils. J. Allergy Clin. Immunol. 100:283-287.
2. Desreumaux, P., A. Janin, J.F. Colombel, L. Prin, J. Plumas, D. Emilie, G. Torpier, A. Capron, and M. Capron. 1992. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J. Exp. Med. 175:293-296.
3. Dubucquoi, S., P. Desreumaux, A. Janin, O. Klein, M. Goldman, J. Tavernier, A. Capron, and M. Capron. 1994. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J. Exp. Med. 179:703-708.
4. Nonaka, M., R. Nonaka, K. Woolley, E. Adelroth, K. Miura, Y. Ohkawara, M. Glibetic, K. Nakano, P. O'Byrne, J. Dolovich, and M. Jordana. 1995. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils. J. Immunol. 155:3234-3244.
5. Moqbel, R., S. Yin, J. Barkans, T.M. Newman, P. Kimmitt, M. Wakelin, L. Taborda-Barata, Q. Meng, C.J. Corrigan, S.R. Durham, and A.B. Kay. 1995. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J. Immunol. 155: 4939-4947.
6. Nakajima, H., G.J. Gleich, and H. Kita. 1996. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J. Immunol. 156:4859-4866.
7. Woerly, G., N. Roger, S. Loiseau, and M. Capron. 1999. Expression of Th1 and Th2 immunoregulatory cytokines by human eosinophils. Int. Arch. Allergy Immunol. 118:95-97.
8. Weller, P.F., and G.J. Bubley. 1994. The idiopathic hypereosinophilic syndrome. Blood. 83:2759-2779.
9. Lamkhioued, B., A. Soussi-Gounni, D. Aldebert, E. Delaporte, L. Prin, A. Capron, and M. Capron. 1996. Synthesis of type 1 (IFN-γ) and type 2 (IL-4, IL-5, and IL-10) cytokines by human eosinophils. Ann. NY Acad. Sci. 796:203-208.
10. Levi-Schaffer, F., J. Barkans, T.M. Newman, S. Ying, M. Wakelin, R. Hohenstein, V. Barak, P. Lacy, A.B. Kay, and R. Moqbel. 1996. Identification of interleukin-2 in human peripheral blood eosinophils. Immunology. 87:155-161.
11. Grewe, M., W. Czech, A. Monta, T. Werfel, M. Klammer, A. Kapp, T. Ruzicka, E. Schöpf, and J. Krutmann. 1998. Human eosinophils produce biologically active IL-12. Implications for control of T cell responses. J. Immunol. 161:415-420.
12. Lucey, D.R., A. Nicholson-Weller, and P.P. Weller. 1989. Mature human eosinophils have the capacity to express HLA-DR. Proc. Natl. Acad. Sci. USA. 86:1348-1351.
13. Ohkawara, Y., K.G. Lim, Z. Xing, M. Glibetic, K. Nakano, J. Dolovich, K. Croitoru, P.F. Weller, and M. Jordana. 1996. CD40 expression by human peripheral blood eosinophils. J. Clin. Invest. 97:1761-1766.
14. Gauchat, J.-F., S. Henchoz, D. Fattah, G. Mazzei, J.-P. Aubry, T. Jomotte, L. Dash, K. Page, R. Solari, D. Aldebert, et al. 1995. CD40 ligand is functionally expressed on human eosinophils. Eur. J. Immunol. 25:863-865.
15. Weller, P.F., T.H. Rand, T. Barrett, A. Elovic, D.T.W. Wong, and R.W. Finberg. 1993. Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen presentation and IL-1α expression. J. Immunol. 150: 2554-2562.
16. Del Pozo, V., B. De Andres, E. Martin, B. Cardaba, J.C. Fernandez, S. Gallardo, P. Tramon, F. Leyvacobian, P. Palomino, and C. Lahoz. 1992. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing. Eur.J. Immunol. 22:1919-1925.
17. Lenschow, D.J., T.L. Walunas, and J.A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
18. Linsley, P.S., W. Brady, L. Grosmaire, A. Aruffo, N.K. Damle, and J.A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173: 721-730.
19. Freeman, G.J., F. Borrelio, R.J. Hodes, H. Reiser, J.G. Gribben, J.W. Ng, J. Kim, J.M. Goldberg, K. Hathcock, G. Laszlo, et al. 1993. Murine B7-2, an alternative CTLA-4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178:2185-2192.
20. June, C.H., J.A. Bluestone, L.M. Nadler, and C.B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today. 15:321-331.
21. Hathcock, K.S., G. Laszlo, C. Pucillo, P. Linsley, and R.J. Hodes. 1994. Comparative analysis of B7.1 and B7.2 costimulatory ligands: expression and function. J. Exp. Med. 180: 631-640.
22. Kuchroo, V., M. Prabbu-Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules differentially activate the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:707-718.
23. Hansel, T.T., I.J.M. De Vries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods. 145:105-110.
24. Decker, T., and M.L. Lohmann-Matthes. 1988. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods. 115:61-69.
25. Pfizenmaier, K., H. Bartsch, P. Scheurich, B. Seliger, U. Ucer, K. Vehmeyer, and G.A. Nagel. 1985. Differential γ-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of γ-interferon on tumor cell. Growth Cancer Res. 45:3503-3509.
26. Soussi-Gounni, A., B. Lamkhioued, M. Monta, D. Aldebert, M. Sarfati, A. Capron, and M. Capron. 1998. Molecular characterization of the low-affinity IgE receptor FceRII/ CD23 expressed by human eosinophils. Int. Immunol. 10: 395-404.
27. Aruffo, A., and B. Seed. 1987. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA. 84:8573-8577.
28. Rand, T.H., W.W. Cruikshank, D.M. Center, and P.F. Weller. 1991. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J. Exp. Med. 173: 1521-1528.
29. Azuma, M., H. Yssel, H. Philipps, H. Spits, and L.L. Lanier. 1993. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177:845-850.
30. Siefken, R., S. Klem-Hessling, E. Serfling, R. Kurrle, and R. Schwinzer. 1998. A CD28-associated signaling pathway leading to cytokine gene transcription and T cell proliferation without TCR engagement. J. Immunol. 161:1645-1651.
31. Bossé, M., M. Audette, C. Ferland, G. Pelletier, H.W. Chu, A. Dakhama, S. Lavigne, L.-P. Boulet, and M. Laviolette. 1996. Gene expression of interleukin-2 in purified human peripheral blood eosinophils. Immunology. 87:149-154.
32. Pretolani, M., and M. Goldman. 1997. IL-10: a potential therapy for allergic inflammation? Immunol. Today. 18:277-280.